Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Interesting - Thank You for pointing this out!
The reason there wasn't any new warrants is because the company that will be buying us out already has the buyout conversion already calculated.
The Buyout price in Cash and
So many new Shares in their company.
They told Linda NO MORE WARRANTS - Take a Loan
Don't Make Me Leak
By the way: Two weeks is plenty of time to retrieve the final data reports/graphs.
All they have to do is place the new data inside of an excel format insert that excel file into their database tables and run the list of jobs to complete the process. The jobs should be READY TO GO
That's my point - The jobs should be READY TO GO
All the programming should be complete with the previous data setups.
Even with only 10% of the data retrieved the jobs should be created and tested and ready to go
I'm doing this all day with my data(work) - I'm also late with three data feeds into an outside server.
Would I love to have access to their database?
And run some PowerBI reports It would be awesome!
The Company's lead program is a 331-patient Phase III trial of DCVax(R)-L for newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease." The Company is also pursuing development of DCVax(R)-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial, and is preparing for Phase II trials. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania.
The Company currently continues to anticipate reporting topline trial data in September, and anticipates providing further updates as the process progresses.
We have news
NW Bio Announces Completion of Further Data Gathering For Phase III Trial NWBO
BETHESDA, Md., Aug. 19, 2020 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO)("NW Bio"), a biotechnology company developing DCVax(R) personalized immune therapies for solid tumor cancers, today announced that the remaining outstanding clinical trial data for the Company's Phase 3 trial of DCVax(R)-L for Glioblastoma brain cancer as described in the Company's last report on July 24, 2020 has now been completed by the specialty analytics firms. With this data now in hand, final quality control checking and confirmation are under way to enable Data Lock. This further data involves specialty analytics such as genomic profiling for IDH mutations and certain imaging. The independent CRO managing the trial is now integrating this data into the overall trial database containing the clinical data from the trial sites that was already complete and locked as reported on July 24, 2020, in order to complete the overall trial dataset. When Data Lock is reached, the independent statisticians will be given access to the unblinded dataset. The Company will remain blinded while the statisticians make the computations, converting the mass of raw data from the trial into formal tables and listings, and survival and progression measures, to report the trial results. As previously reported, the statisticians' work is estimated to take a couple of weeks. When their computations are completed, the Company will receive the results of those computations and thereby become unblinded. It is anticipated that the Company's Scientific Advisory Board, the Steering Committee of the Trial and other key medical expert advisors will likewise receive the results, and thereby become unblinded as well. The Company currently continues to anticipate reporting topline trial data in September, and anticipates providing further updates as the process progresses. About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the North America and Europe. The Company has a broad platform technology for DCVax(R) dendritic cell-based vaccines. The Company's lead program is a 331-patient Phase III trial of DCVax(R)-L for newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an "orphan disease." The Company is also pursuing development of DCVax(R)-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial, and is preparing for Phase II trials. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania. Disclaimer Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "believe," "intend," "design," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we actually will achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results may differ materially from those projected in any forward-looking statement. Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as risks related to the Company's ability to enroll patients in its clinical trials and complete the trials on a timely basis, uncertainties about the clinical trials process, uncertainties about the timely performance of third parties, risks related to whether the Company's products will demonstrate safety and efficacy, risks related to the Company's ongoing ability to raise additional capital, and other risks included in the Company's Securities and Exchange Commission ("SEC") filings. Additional information on the foregoing risk factors and other factors, including Risk Factors, which could affect the Company's results, is included in its SEC filings. Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws. CONTACTS Dave Innes Les Goldman 804-513-4758 dinnes@nwbio.com 240-234-0059
For those who do not watch the trades take place during the day.
We have a vast majority of trades taken place at the ASK. (Green)
And many somewhat larger trades
Please don't tell me its only .33 cents range and vol does not mean much.
Its the change from day to day that stands out
Scotty - why is the price higher than that 1 million trade if it was a dump?
Teach me Scotty -- Teach me !
I will look into it
If only investment Property - great - if true
But they must of left that off
If you sell your house today - you don't pay taxes if you purchase another property that cost more then your previous property.
you roll your gains into the next property
Nice volume today .
Now lets see the price move
Just heard that sleepy Joe will get rid of the 1031 tax credit
If you sell your home you must pay tax on your profit of your home.
you cannot roll over the profit into your new house
ugh
tax tax tax tax tax
Ok then
I'm going to the eye doctor when the market closes ...
Maybe the foot doctor too -- foot in mouth
Maybe it doesn't trade pre-market but the trade took place.
At 9:02:20 est
Between Market Makers ??
Don't Make Me Leak
Sorry - We were addressing the World Wide dominance by China
China is found in South America and Africa Draining all the resources.
Nothing New with moving in but they don't care about the people or countries
UPS preparing freezers for the Covid vaccine when its ready. (Storage)
A couple of locations.
I'm thinking we can use those facilities when we are ready ....
I think they said it can hold 600 freezers holding 40,000 vaccines
Minus 112 Fahrenheit
Netherlands and Louisville
One item that will affect us all depending on November is Capital Gains Tax. Now that is a can of Worms
That can be a discussion in itself.
She moves around I think Zambia and the countries that border
Siemens Healthineers to acquire cancer treatment company Varian for $16.4B
Deal is expected to close in the first half of 2021
BERLIN (Reuters) - German health group Siemens Healthineers said on Sunday it would acquire Varian Medical Systems Inc in a deal that values the U.S. maker of devices and software for cancer treatments at $16.4 billion.
Under the agreed transaction, Siemens Healthineers will acquire all shares in Varian for $177.50 each in cash, representing a 24% premium to the U.S. company’s closing price on Friday.
Industrial conglomerate Siemens, which spun off Healthineers in 2018 but retains a controlling stake, will provide bridge financing for the deal, which seeks to create a global leader in cancer care solutions by 2025.
"With this combination of two leading companies we make two leaps in one step: A leap in the fight against cancer and a leap in our overall impact on healthcare," said Bernd Montag, CEO of Siemens Healthineers.
I have a niece in Africa as a missionary and she gives me updates.
They are controlling all the minerals and anything else that is valuable.
They force people to work with no regards to the virus. Just fill in with the next body
First Hand Info from my Niece
Sorry if this offends anyone
I'm sure that what you say is correct
California - New York my guess
Property write offs
When policy comes out of Washington it's for the entire country and the entire economy. They can't help that taxes are higher in some states.
heck - I'm in Illinois and we are broke -- Dems running the state for years
Not the Gov but State congress spending money
Doesn't Illinois have the most gov taking that slow walk to jail LOL
Take it Down ---Who cares
If it makes you happy -
I would like you to have a great day !
Nobody is going to convince anyone of anything these days
I just wish he would come out of the basement and talk a little and take questions
LOL
No clue what your talking about
The Daily Beast ! LOLOLOLOLOL
I guess all the other Doc's behind here were Quacks also
Ok - Maybe I used the wrong wording
Jacked UP
All Im saying is that if someone gets tested 4 times they are counting it for 4 people thats it
No big deal - not even important on this board
sorry for bringing it up --- nobody is going to convince anyone of anything .
I just may know some people that can verify
Yes - Closed system - I remember that she mentioned that she was working with the best companies to achieve this... I think she said world class
Many more stories like this one coming soon !
Grateful to be a 22-year brain tumor survivor. Fortunate to get immunotherapy at UCLA! I also appreciate CRI Cancer Immunotherapy Month, including CRI's Wear White Day!
@UCLAJCCC
@CancerResearch
#immune2cancer #immunotherapy #cancer #braintumor #braincancer #gratitude #resilience
Jeannine Walston
Cancer Coach, Health & Wellness Coach, Consultant, Speaker, Integrative Expert & 21-Year Brain Tumor Survivor http://jeanninewalston.com http://healingfocus.org
Los Angeles, CaliforniaJoined July 2012
Yes for the newbies -- it was DCVAX
If that is the case Great
If not - Its not that big a deal
Lets get to the finish line PERIOD
So many years - 1 more dilution if needed then they need it
If a dilution takes place - At this point its a nothing Burger.
What this stock / vaccine can do for people is nothing short of gargantuan.
I imagine so many people hoping and praying that time go their way and able to receive this vaccine.
So yes dilution = Nothing Burger
On the stock side of things - Everyone has been given the gift to add more shares. If taken advantage of the price great if not go with the flow
Don't Make Me Leak
Anders - you have the wrong person but thats ok ---
I was so excited I forgot to open the entire article before I listed it
Don't Make Me Leak
Northwest Biotherapeutics Announces Completion of Phase 3 Trial Sites' Databases
As noted in the Company's prior reports, in order to reach overall data lock for the Trial, each site's data must go through final collection, review, checking for queries, resolution of queries preparatory steps for locking the site and finally personal sign-off by the lead investigator at each site for that site's data. For that purpose, the lead investigator must undergo training on the system, review the site data, personally complete the confirmation and deliver it to the independent contract research organization (CRO) managing the Trial.
- ADVERTISEMENT -
Reaching these personal sign-offs by each lead investigator at each of the Trial sites has been a key focus of activity towards data lock for the last couple of months, especially during June and July. At the time of the Company's last report near the end of June, about 30 Trial sites were in varying stages of progress towards sign-off, and about half a dozen Trial sites had not yet completed the preparatory steps necessary to begin the process towards such sign-off.
All of the Trial sites are now finished. The independent CRO has obtained all of the investigator sign-offs for their site's data lock. The sites' data includes all of the clinical data gathered in the Case Report Forms throughout the Trial, and now sit in a signed off, locked position with the CRO.
These datasets from each of the Trial sites (hospitals) are the largest component of the overall dataset for the Trial and contain most of the data. The remaining information for the overall Trial dataset includes some analyses from specialized service providers who are separate from the Trial site hospitals. Such analyses include, for example, genetic profiles such as IDH mutations. For some of these analyses, it has been necessary to go back and obtain additional material due to the age of the samples. For other analyses, it has been necessary to have the analyses done by two separate experts as a cross-check.
This process continues to be impacted by the effects of COVID-19, especially with the resurgence of COVID cases in many areas. For example, key experts at certain specialized service providers have been unavailable for periods of time due to illness in their family. Other experts have gone on extended leave due to restrictions on operations. However, the CRO and the Company are working intensively with these vendors on a continuous basis to move as quickly as possible.
The Company currently anticipates that the remaining analyses by these specialty service providers will be completed within the next couple weeks. When this external data joins the now locked data from the Trial sites, the overall Trial dataset will be locked.
Following completion of the Trial data lock, the independent statisticians will be given access to the raw data in the Trial database, and will undertake the calculations and the preparations of the Tables and Listings which provide the Trial results. The Company anticipates that the statisticians' work will take several weeks.
Holy Cow - Many large trades - Makes you Wonder
250,000 shares after 85,000 shares
Could be connected
Plus crazy volume today - could be a financing deal coming
Something is cooking - good or Bad -- its cooking
Back to my sql
Anyone Leaking yet ???
Can Advent produce all the vaccines if expansion takes place.
All Solid Tumors -- Heck 80% of worldwide Gilo's
Just Asking - I'm not looking short term which is very short if things start moving quickly
Don't Make Me Leak
Very Interesting - Im all for it !
Let's roll
That's different Bid .05 Ask .39
This trading day was a eye opening also - 2.9 million shares traded
Well at least something is going on
LOL
Don't Make Me Leak
Nice Post Dan88 --- All true -- Nothing to do but relax and wait
We are on their timeline nothing will change it
Don't Make Me Leak
Crazy
A trade just executed at .345225 for 2,000 shares
Never seen so many decimals before
I agree with all of your points
I just like to pick which shares to sell else yes default to the setup with the broker.
Paying the Tax, I also agree and was wondering about the penalty when selling here. My guess is that many people here will be paying their taxes on profits before the end of the year.
I was wondering if the month you pay means anything. Paying in Aug vs Dec ? I would like to keep the profit/invest the profit for as long as I can.
When dealing with 15k shares - can't be much profit now
Come on Scotty - I set you up for a very good profit post - go for it
Yes - tax time next year
Being away from home - all you have is the communication with your broker by phone
or can you access your account on your phone
Most if not all have the capability to view all your purchases and select which buys you would like to sell therefore you can select which prices or in case of a profit which buys you have owned for more than a year.
Heck - If your out in the wilderness - maybe just sell and don't worry about it --- your not selling 200,000 shares
Have a great time out there !!!!
Sell your most expensive shares - maybe you can take a loss if you don't buy back in the next 30 days.
Else sell you older shares so you can pay the lower tax on your profit
Else if a Roth --- just pay your bills LOL
AstraZeneca PLC and Merck & Co. on Wednesday said the European Commission approved their cancer drug Lynparza in a form of pancreatic cancer.
floppies ????
Now that's funny --- it was meant to be right?